Related Experiment Video
Updated: Jun 17, 2026

Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices
Published on: September 8, 2023
Pathomechanisms and treatment of pediatric aneurysms
Timo Krings1, Sasikhan Geibprasert, Karel G terBrugge
1Division of Neuroradiology, Department of Medical Imaging, Toronto Western Hospital, UHN, University of Toronto, 399 Bathurst St., 3MCL-429, Toronto, ON, M5T 2S8, Canada. timo.krings@uhn.on.ca
Insights
Pediatric aneurysms, rare and distinct from adult types, necessitate tailored treatments. Key causes include trauma, infection, and dissection, with unique locations and clinical presentations requiring specific management approaches.
Area of Science:
- Pediatric Neurology
- Vascular Surgery
- Neuroradiology
Background:
- Pediatric aneurysms are rare and differ significantly from adult aneurysms, necessitating distinct diagnostic and therapeutic strategies.
- Commonly observed in children are saccular aneurysms, alongside those resulting from trauma, infection, or dissection.
- Pediatric aneurysms frequently affect the posterior circulation and distal vessels, with a notable male predominance.
Purpose of the Study:
- To delineate the distinct characteristics and pathomechanisms of pediatric aneurysms.
- To outline the varied clinical presentations beyond subarachnoid hemorrhage.
- To discuss the specialized treatment modalities for pediatric aneurysms.
Main Methods:
- Review of pediatric aneurysm cases focusing on etiology (trauma, infection, dissection) and location.
- Analysis of clinical findings, including mass effects, headaches, and neurological deficits.
- Evaluation of treatment outcomes for various aneurysm types.
Main Results:
- Traumatic aneurysms often occur in the skull base or distal anterior communicating artery, with delayed hemorrhage.
- Infectious aneurysms, typically bacterial, present with early hemorrhage post-septic emboli.
- Dissecting aneurysms are most common in children, potentially causing mass effect, hemorrhage, or ischemia.
Conclusions:
- Pediatric aneurysms require individualized treatment based on their specific pathomechanism and location.
- Endosaccular coiling is suitable for berry-type aneurysms, while other types may need parent vessel occlusion, flow reversal, or surgical interventions.
- Combined treatment approaches, including bypass with parent vessel occlusion, are essential for complex pediatric aneurysms.
Abstract:
Pediatric aneurysms are rare diseases distinct from classical adult aneurysms and therefore require different treatment strategies. Apart from saccular aneurysms that are more commonly found in older children, three major pathomechanisms may be encountered: trauma, infection, and dissection. The posterior circulation and more distal locations are more commonly encountered in children compared to adults, and there is an overall male predominance. Clinical findings are not only confined to subarachnoid hemorrhage but may also comprise mass effects, headaches or neurological deficits. In traumatic aneurysms, the skull base and distal anterior communicating artery are commonly affected, and the hemorrhage occurs often delayed (2-4 weeks following the initial trauma). Infectious aneurysms are mostly bacterial in origin, and hemorrhage occurs early after a septic embolic shower. Dissecting aneurysms are the most often encountered aneurysm type in children and can lead to mass effect, hemorrhage, or ischemia depending on the fate of the intramural hematoma. Treatment strategies in pediatric aneurysms include endosaccular coil treatment only for the "classical berry-type" aneurysms; in the other instances, parent vessel occlusion, flow reversal, surgical options, or a combined treatment with bypass and parent vessel occlusion have to be contemplated.
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm I: Introduction
Aortic Regurgitation III: Medical Management
Aneurysm IV: Nursing Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

